HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicholas A Piazza Selected Research

sulindac sulfide amide

5/2013A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicholas A Piazza Research Topics

Disease

1Non-alcoholic Fatty Liver Disease
02/2016
1Fibrosis (Cirrhosis)
02/2016
1Heart Failure
02/2016
1Pulmonary Hypertension
02/2016
1Infections
02/2016
1Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
02/2016
1Stroke (Strokes)
02/2016
1Cardiac Arrhythmias (Arrythmia)
02/2016
1Coronary Disease (Coronary Heart Disease)
02/2016
1Adenocarcinoma of Lung
05/2013
1Neoplasms (Cancer)
05/2013

Drug/Important Bio-Agent (IBA)

1SmokeIBA
02/2016
1sulindac sulfide amideIBA
05/2013
1AminesIBA
05/2013
1Antineoplastic Agents (Antineoplastics)IBA
05/2013
1sulindac sulfideIBA
05/2013
1Sulindac (Copal)FDA LinkGeneric
05/2013

Therapy/Procedure

1Liver Transplantation
02/2016
1Therapeutics
05/2013